推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 “小亂散”局面亟待改善？中藥材流通迎“整頓”，日前商務(wù)部印發(fā)《全國(guó)中藥材物流基地規(guī)劃建設(shè)指引》，引導(dǎo)中藥材物流基地合理布局與規(guī)范建設(shè)，加快建設(shè)全國(guó)中藥材現(xiàn)代物流體系。而記者梳理發(fā)現(xiàn)，此番指引還特別強(qiáng)調(diào)了加強(qiáng)與金融機(jī)構(gòu)進(jìn)行合作，幫助客戶獲得市場(chǎng)融資。
據(jù)了解，目前我國(guó)中藥材流通依然處于“小亂散”局面，大幅落后于我國(guó)物流發(fā)展平均水平。此前商務(wù)部有關(guān)調(diào)研顯示，長(zhǎng)期以來(lái)，中藥材種植以農(nóng)戶為主體，中藥材流通以專業(yè)市場(chǎng)為主渠道，個(gè)體商戶及中小企業(yè)是專業(yè)市場(chǎng)的經(jīng)營(yíng)主體。而中藥材初加工與包裝技術(shù)落后，不便儲(chǔ)存與信息管理，相應(yīng)物流標(biāo)準(zhǔn)體系也不完善，再加上中藥材行業(yè)“頑疾”染色摻假依然盛行，導(dǎo)致“整頓”勢(shì)在必行。此番指引出爐被認(rèn)為有利于中藥材流通市場(chǎng)規(guī)范化，或能有效改變市場(chǎng)“小亂散”現(xiàn)狀。
記者了解得知，指引要求，物流基地必須有具備符合市場(chǎng)需求與相關(guān)標(biāo)準(zhǔn)的中藥材專業(yè)倉(cāng)庫(kù)，而且要按照《藥典》要求對(duì)中藥材進(jìn)行質(zhì)量檢驗(yàn)。此外，中藥材物流基地還應(yīng)根據(jù)市場(chǎng)需求提供中藥材的初加工與包裝服務(wù)。
值得關(guān)注的是，該指引還針對(duì)當(dāng)前市場(chǎng)潮流提出了兩項(xiàng)新要求：一是物流基地應(yīng)與中藥材專業(yè)市場(chǎng)、全國(guó)性中藥材電子商務(wù)公共平臺(tái)加強(qiáng)合作，實(shí)現(xiàn)資源與信息共享，為客戶積極拓展?fàn)I銷渠道；二是與相關(guān)金融機(jī)構(gòu)加強(qiáng)合作，為中藥材擔(dān)保融資提供存貨監(jiān)管服務(wù)，幫助客戶獲得市場(chǎng)融資。但物流基地的經(jīng)營(yíng)行為不能與客戶利益發(fā)生沖突。對(duì)此，該指引解釋稱，這是因?yàn)槟壳皣?guó)內(nèi)藥農(nóng)很分散，中藥材經(jīng)銷商規(guī)模也很小。為了吸引廣大藥農(nóng)和經(jīng)銷商使用中藥材加工、包裝和倉(cāng)儲(chǔ)服務(wù)，物流基地可提供“集中倉(cāng)儲(chǔ)”以外的增值服務(wù)，為其創(chuàng)造附加收益。
